Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China
Jing Wang, Jian Du, Yan Liu, Yuyang Xu, Jiayin Han, Xuechao Zhang, Peter Maple · 2024
Read Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China by Jing Wang, Jian Du, Yan Liu, Yuyang Xu, Jiayin Han, Xuechao Zhang, Peter Maple (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11680005.txt.
Description
Jing Wang and colleagues watch adverse events after the shingles vaccine in older adults in Hangzhou. Their surveillance study from twenty twenty-four covers the first years after launch in China. The recombinant vaccine protects against painful shingles. Post-marketing data confirm safety in real local populations.
Two hundred seventy-five event reports followed vaccination in the city. The reporting rate was well under one per thousand doses. Only one case was classed as serious overall. Women and the youngest eligible age group reported more events. First doses drew more reports than second doses. Nearly all events were ordinary vaccine reactions. Local data reassure older adults considering the shot.
Catalog record
| CREATOR | Jing Wang, Jian Du, Yan Liu, Yuyang Xu, Jiayin Han, Xuechao Zhang, Peter Maple |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |